ALKERMES | ALKS - Trade Debtors


ALKERMES reported $355.11M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
ALKERMES USD 355.11M 1.22M Sep/2025
Amgen USD 9.57B 1.08B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Coherus Biosciences USD 62.44M 59.9M Mar/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
J&J USD 17.61B 235M Sep/2025
Malin Corporation EUR 500K 300K Dec/2024
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Otsuka Holdings JPY 570.32B 39.96B Dec/2025
Ovoca Bio EUR 447K 113K Jun/2022
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025